Skip to main content
. 2017 Sep 19;8(47):83280–83291. doi: 10.18632/oncotarget.21059

Figure 2. Forest plot for meta-analysis of incidence of all-grade and high-grade cuSCC.

Figure 2

Each study was shown by the name of the lead author and year of publication. The summary incidences were also shown in the figure. Plots are arranged as follows: (A) Incidence of all-grade cuSCC by BRAF inhibitor; (B) Incidence of high-grade cuSCC by BRAF inhibitor; (C) Incidence of all-grade cuSCC by dual BRAF/MEK inhibitors; (D) Incidence of high-grade cuSCC by dual BRAF/MEK inhibitors.